Daniela Alberati

Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia

Daniel Umbricht, Daniela Alberati, Meret Martin‐Facklam et al. · JAMA Psychiatry · 2014 · 230 citations

Medicine, Pharmacology, Psychiatry +16

Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((<i>S</i>)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia

Emmanuel Pinard, Alexander Alanine, Daniela Alberati et al. · Journal of Medicinal Chemistry · 2010 · 134 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia

Daniela Alberati, Jean‐Luc Moreau, Judith A. Lengyel et al. · Neuropharmacology · 2011 · 126 citations

Medicine, Pharmacology, Psychiatry +10

Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal–lesioned rats: reversal by glycine and a glycine transporter inhibitor

Gwenaëlle Le Pen, James N.C. Kew, Daniela Alberati et al. · Biological Psychiatry · 2003 · 107 citations

Life Sciences, Neurobiology, Neuroscience +17

Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression

Laetitia Gabernet, Meike Pauly-Evers, Cornelia Schwerdel et al. · Neuroscience Letters · 2004 · 90 citations

Life Sciences, Neurobiology, Neuroscience +10